Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
Merck
Queensland Health
AstraZeneca
Chinese Patent Office
US Department of Justice
Cerilliant

Generated: June 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ioversol

« Back to Dashboard

ioversol

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC N 0019-1323-00
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC N 0019-1323-02
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC N 0019-1323-04
Liebel-flarsheim OPTIRAY 160 ioversol INJECTABLE;INJECTION 019710 NDA Liebel-Flarsheim Company LLC N 0019-1323-06
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Daiichi Sankyo
Merck
US Army
Healthtrust
Harvard Business School
Queensland Health
McKinsey